The drugmaker is introducing a new, more convenient way to inject its blockbuster obesity drug, Zepbound. Eli Lilly, the drugmaker behind weight-loss treatments Mounjaro and Zepbound, has rapidly ...

GLP-1 medications, such as Ozempic and Wegovy, are injected into the fatty layer beneath the skin to manage blood sugar and aid in weight management. The recommended injection sites include the ...

Demand for GLP-1 drugs such as semaglutide is exposing capacity gaps across peptide APIs, sterile fill-finish facilities, ...

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

Glucagon-like peptide-1 receptor agonists (GLP-1s) have become well known for their significant role as an aid in weight loss ...

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

Eli Lilly, the drugmaker behind weight-loss treatments Mounjaro and Zepbound, has rapidly overtaken former market leader Novo Nordisk in the obesity drug race. While Novo’s shares have struggled this ...

have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, , MD, an endocrinologist and assistant ...